Coloplast A/S (OTCMKTS:CLPBY) Shares Climb 15.2% – What’s Next?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report)’s share price was up 15.2% during mid-day trading on Wednesday. The stock traded as high as $7.84 and last traded at $7.7750. Approximately 42,445 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 429,517 shares. The stock had previously closed at $6.75.

Coloplast A/S Price Performance

The company has a fifty day simple moving average of $6.82 and a 200-day simple moving average of $6.80. The company has a market cap of $17.87 billion, a P/E ratio of 41.74, a PEG ratio of 2.40 and a beta of 0.10. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94.

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.09 earnings per share for the quarter, hitting the consensus estimate of $0.09. The business had revenue of $1.12 billion during the quarter, compared to analyst estimates of $1.12 billion. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. On average, sell-side analysts predict that Coloplast A/S Sponsored ADR will post 0.40 earnings per share for the current year.

About Coloplast A/S

(Get Free Report)

Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.

Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.

See Also

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.